Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) Return on Sales (2024 - 2025)

Rallybio's Return on Sales history spans 2 years, with the latest figure at 75.55% for Q3 2025.

  • For Q3 2025, Return on Sales rose 11176.0% year-over-year to 75.55%; the TTM value through Sep 2025 reached 20.17%, up 8778.0%, while the annual FY2024 figure was 92.56%, N/A changed from the prior year.
  • Return on Sales for Q3 2025 was 75.55% at Rallybio, up from 44.42% in the prior quarter.
  • Across five years, Return on Sales topped out at 75.55% in Q3 2025 and bottomed at 5307.0% in Q4 2024.